Hemopoietic progenitor cell identification in fetal and adult blood
Hemopoietic progenitor cells give rise to all cellular elements of the blood and are of importance as a potential source of cells used for correction of various pathological conditions. The main objective of this study was to identify and quantitative hemopoietic progenitor cell in antenatal fetal blood, in cord blood at the time of delivery and in adult blood, using monoclonal antibodies to surface markers and flow cytometry. CD34+ cells, most of them probably representing progenitor cells, were detected in prenatal fetal blood as early as the 17th week of gestation. The proportion of these cells showed a tendency to decrease as the pregnancy progressed. Within the population of CD34+ cells, a relatively low proportion (less than 1%) were negative for the surface marker CD33 or HLA-Dr, indicating a population of primitive stem cells, i.e., progenitor cells no committed to a specific lineage. On the contrary, another group coexpressed CD33 or HLA-Dr, being more mature progenitor cells already committed to differentiate along a specific lineage. The percentage of CD34+ obtained in blood of adult patients after mobilization with chemotherapeutic agents and growth factors showed an average value of 2.7± 3.1%. The percentage of CD34+ in the apheresis products of various patients varied from 0.58 to 1.48. In some cases the cells were reinfused in the patient with good results. Our findings are in agreement with previous studies suggesting that CD34+ stem cells is a heterogeneous population, with each subset having variable degree o commitment to differentiate toward a specific cell lineage.
Main Authors: | , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular
2008
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800006 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1516-84842008000800006 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1516-848420080008000062008-12-09Hemopoietic progenitor cell identification in fetal and adult bloodMüller,AixaSoyano,AndrésGuevara,FreddyMartínez,BahildaSoyano,AlbertoPonte,Benita Hemopoietic progenitor cell flow cytometry CD34+ cells apheresis mobilization cord blood Hemopoietic progenitor cells give rise to all cellular elements of the blood and are of importance as a potential source of cells used for correction of various pathological conditions. The main objective of this study was to identify and quantitative hemopoietic progenitor cell in antenatal fetal blood, in cord blood at the time of delivery and in adult blood, using monoclonal antibodies to surface markers and flow cytometry. CD34+ cells, most of them probably representing progenitor cells, were detected in prenatal fetal blood as early as the 17th week of gestation. The proportion of these cells showed a tendency to decrease as the pregnancy progressed. Within the population of CD34+ cells, a relatively low proportion (less than 1%) were negative for the surface marker CD33 or HLA-Dr, indicating a population of primitive stem cells, i.e., progenitor cells no committed to a specific lineage. On the contrary, another group coexpressed CD33 or HLA-Dr, being more mature progenitor cells already committed to differentiate along a specific lineage. The percentage of CD34+ obtained in blood of adult patients after mobilization with chemotherapeutic agents and growth factors showed an average value of 2.7± 3.1%. The percentage of CD34+ in the apheresis products of various patients varied from 0.58 to 1.48. In some cases the cells were reinfused in the patient with good results. Our findings are in agreement with previous studies suggesting that CD34+ stem cells is a heterogeneous population, with each subset having variable degree o commitment to differentiate toward a specific cell lineage.info:eu-repo/semantics/openAccessAssociação Brasileira de Hematologia e Hemoterapia e Terapia CelularRevista Brasileira de Hematologia e Hemoterapia v.30 suppl.2 20082008-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800006en |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Müller,Aixa Soyano,Andrés Guevara,Freddy Martínez,Bahilda Soyano,Alberto Ponte,Benita |
spellingShingle |
Müller,Aixa Soyano,Andrés Guevara,Freddy Martínez,Bahilda Soyano,Alberto Ponte,Benita Hemopoietic progenitor cell identification in fetal and adult blood |
author_facet |
Müller,Aixa Soyano,Andrés Guevara,Freddy Martínez,Bahilda Soyano,Alberto Ponte,Benita |
author_sort |
Müller,Aixa |
title |
Hemopoietic progenitor cell identification in fetal and adult blood |
title_short |
Hemopoietic progenitor cell identification in fetal and adult blood |
title_full |
Hemopoietic progenitor cell identification in fetal and adult blood |
title_fullStr |
Hemopoietic progenitor cell identification in fetal and adult blood |
title_full_unstemmed |
Hemopoietic progenitor cell identification in fetal and adult blood |
title_sort |
hemopoietic progenitor cell identification in fetal and adult blood |
description |
Hemopoietic progenitor cells give rise to all cellular elements of the blood and are of importance as a potential source of cells used for correction of various pathological conditions. The main objective of this study was to identify and quantitative hemopoietic progenitor cell in antenatal fetal blood, in cord blood at the time of delivery and in adult blood, using monoclonal antibodies to surface markers and flow cytometry. CD34+ cells, most of them probably representing progenitor cells, were detected in prenatal fetal blood as early as the 17th week of gestation. The proportion of these cells showed a tendency to decrease as the pregnancy progressed. Within the population of CD34+ cells, a relatively low proportion (less than 1%) were negative for the surface marker CD33 or HLA-Dr, indicating a population of primitive stem cells, i.e., progenitor cells no committed to a specific lineage. On the contrary, another group coexpressed CD33 or HLA-Dr, being more mature progenitor cells already committed to differentiate along a specific lineage. The percentage of CD34+ obtained in blood of adult patients after mobilization with chemotherapeutic agents and growth factors showed an average value of 2.7± 3.1%. The percentage of CD34+ in the apheresis products of various patients varied from 0.58 to 1.48. In some cases the cells were reinfused in the patient with good results. Our findings are in agreement with previous studies suggesting that CD34+ stem cells is a heterogeneous population, with each subset having variable degree o commitment to differentiate toward a specific cell lineage. |
publisher |
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular |
publishDate |
2008 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000800006 |
work_keys_str_mv |
AT mulleraixa hemopoieticprogenitorcellidentificationinfetalandadultblood AT soyanoandres hemopoieticprogenitorcellidentificationinfetalandadultblood AT guevarafreddy hemopoieticprogenitorcellidentificationinfetalandadultblood AT martinezbahilda hemopoieticprogenitorcellidentificationinfetalandadultblood AT soyanoalberto hemopoieticprogenitorcellidentificationinfetalandadultblood AT pontebenita hemopoieticprogenitorcellidentificationinfetalandadultblood |
_version_ |
1756423450688225280 |